Canadian law firm Davis LLP has strengthened its life sciences department with the addition of Sara Zborovski as partner.
Zborovski assists companies in navigating the regulatory landscape imposed by the Food and Drugs Act and advocates before all branches of Health Canada on behalf of the food and beverage, pharmaceutical, medical device and cosmetic industries.
Rob Seidel, QC, managing partner at Davis, said adding Zborovski to its team would “bring further depth and breadth” to the firm.
"Our clients will benefit from Sara's background and extensive experience acting on matters related to Health Canada issues, as well as her understanding of the regulatory and commercial environment in which they operate," Seidel said.
Davis recently made further additions to its IP and life sciences capabilities with the hiring of Andy Radhakant, Julian Worsley and Neil Fineberg as partners.
Davis LLP is a full-service national law firm with more than 250 lawyers across Canada and in Tokyo, Japan.
You need a subscription to continue reading this content.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
News stories up to a week old and feature articles on the day of publication are accessible with a BASIC FREE ACCOUNT.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’; and for basic access to the latest news on the website and weekly email news alerts choose the 'BASIC FREE ACCOUNT' registration.
life sciences, pharmaceutical, medical, Food and Drugs Act,